Literature DB >> 24794532

P21-activated kinase in inflammatory and cardiovascular disease.

Domenico M Taglieri1, Masuko Ushio-Fukai2, Michelle M Monasky3.   

Abstract

P-21 activated kinases, or PAKs, are serine-threonine kinases that serve a role in diverse biological functions and organ system diseases. Although PAK signaling has been the focus of many investigations, still our understanding of the role of PAK in inflammation is incomplete. This review consolidates what is known about PAK1 across several cell types, highlighting the role of PAK1 and PAK2 in inflammation in relation to NADPH oxidase activation. This review explores the physiological functions of PAK during inflammation, the role of PAK in several organ diseases with an emphasis on cardiovascular disease, and the PAK signaling pathway, including activators and targets of PAK. Also, we discuss PAK1 as a pharmacological anti-inflammatory target, explore the potentials and the limitations of the current pharmacological tools to regulate PAK1 activity during inflammation, and provide indications for future research. We conclude that a vast amount of evidence supports the idea that PAK is a central molecule in inflammatory signaling, thus making PAK1 itself a promising prospective pharmacological target.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac; Cell migration; Cytoskeletal dynamics; NADPH oxidase; PAK1; PAK2

Mesh:

Substances:

Year:  2014        PMID: 24794532      PMCID: PMC4129940          DOI: 10.1016/j.cellsig.2014.04.020

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  166 in total

1.  Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis.

Authors:  Marisa A Gallicchio; Leon A Bach
Journal:  Biochim Biophys Acta       Date:  2013-06-06

2.  Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch.

Authors:  M Lei; W Lu; W Meng; M C Parrini; M J Eck; B J Mayer; S C Harrison
Journal:  Cell       Date:  2000-08-04       Impact factor: 41.582

Review 3.  The transcription factor nuclear factor-kappa B and cancer.

Authors:  R O Escárcega; S Fuentes-Alexandro; M García-Carrasco; A Gatica; A Zamora
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-03       Impact factor: 4.126

4.  Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues.

Authors:  Urbain Weyemi; Bernard Caillou; Monique Talbot; Rabii Ameziane-El-Hassani; Ludovic Lacroix; Odile Lagent-Chevallier; Abir Al Ghuzlan; Dirk Roos; Jean-Michel Bidart; Alain Virion; Martin Schlumberger; Corinne Dupuy
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

Review 5.  PAK thread from amoeba to mammals.

Authors:  Anupam Kumar; Poonam R Molli; Suresh B Pakala; Tri M Bui Nguyen; Suresh K Rayala; Rakesh Kumar
Journal:  J Cell Biochem       Date:  2009-07-01       Impact factor: 4.429

6.  Deficiency of gp91phox inhibits allergic airway inflammation.

Authors:  Carla M Sevin; Dawn C Newcomb; Shinji Toki; Wei Han; Taylor P Sherrill; Madison G Boswell; Zhou Zhu; Robert D Collins; Kelli L Boyd; Kasia Goleniewska; Matthew M Huckabee; Timothy S Blackwell; R Stokes Peebles
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

7.  A p21-activated kinase-controlled metabolic switch up-regulates phagocyte NADPH oxidase.

Authors:  Tali Shalom-Barak; Ulla G Knaus
Journal:  J Biol Chem       Date:  2002-08-19       Impact factor: 5.157

Review 8.  Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

Authors:  Velandai Srikanth; Annette Maczurek; Thanh Phan; Megan Steele; Bernadette Westcott; Damian Juskiw; Gerald Münch
Journal:  Neurobiol Aging       Date:  2009-05-22       Impact factor: 4.673

Review 9.  Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide.

Authors:  Nicolas Grossin; Marie-Paule Wautier; Jean-Luc Wautier
Journal:  Biorheology       Date:  2009       Impact factor: 1.875

10.  The role of p21-activated kinase in the initiation of atherosclerosis.

Authors:  K A Jhaveri; P Debnath; J Chernoff; J Sanders; M A Schwartz
Journal:  BMC Cardiovasc Disord       Date:  2012-07-23       Impact factor: 2.298

View more
  13 in total

1.  Interrogation of kinase genetic interactions provides a global view of PAK1-mediated signal transduction pathways.

Authors:  Jae-Hong Kim; Yeojin Seo; Myungjin Jo; Hyejin Jeon; Young-Seop Kim; Eun-Jung Kim; Donggun Seo; Won-Ha Lee; Sang Ryong Kim; Nozomu Yachie; Quan Zhong; Marc Vidal; Frederick P Roth; Kyoungho Suk
Journal:  J Biol Chem       Date:  2020-10-15       Impact factor: 5.157

Review 2.  p21-activated kinase 1 (PAK1) as a therapeutic target for cardiotoxicity.

Authors:  Ping Guo; Yufeng Liu; Jingrong Feng; Shihang Tang; Fanyan Wei; Jian Feng
Journal:  Arch Toxicol       Date:  2022-09-18       Impact factor: 6.168

3.  Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo.

Authors:  Ahmad Al-Azayzih; Wided N Missaoui; Brian S Cummings; Payaningal R Somanath
Journal:  Nanomedicine       Date:  2016-03-03       Impact factor: 5.307

4.  Ras-Related C3 Botulinum Toxin Substrate 1 Promotes Axonal Regeneration after Stroke in Mice.

Authors:  Lin Liu; Hui Yuan; Yanhua Yi; Edward C Koellhoffer; Yashasvee Munshi; Fan Bu; Yi Zhang; Zhenggang Zhang; Louise D McCullough; Jun Li
Journal:  Transl Stroke Res       Date:  2018-02-24       Impact factor: 6.829

Review 5.  Promoting Glucose Transporter-4 Vesicle Trafficking along Cytoskeletal Tracks: PAK-Ing Them Out.

Authors:  Ragadeepthi Tunduguru; Debbie C Thurmond
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-20       Impact factor: 5.555

6.  Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis.

Authors:  Fiona J Sorrell; Lena Marie Kilian; Jonathan M Elkins
Journal:  Biochem J       Date:  2019-04-04       Impact factor: 3.857

7.  Exploring the Pharmacological Mechanisms of Tripterygium wilfordii Hook F against Cardiovascular Disease Using Network Pharmacology and Molecular Docking.

Authors:  Bingwu Huang; Chengbin Huang; Liuyan Zhu; Lina Xie; Yi Wang; Ning Zhu
Journal:  Biomed Res Int       Date:  2021-08-14       Impact factor: 3.411

Review 8.  Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens.

Authors:  Simona John Von Freyend; Terry Kwok-Schuelein; Hans J Netter; Gholamreza Haqshenas; Jean-Philippe Semblat; Christian Doerig
Journal:  Pathogens       Date:  2017-04-21

9.  Up-regulation of P21-activated kinase 1 in osteoarthritis chondrocytes is responsible for osteoarthritic cartilage destruction.

Authors:  Wanli Ma; Xiaohe Wang; Chunhui Wang; Mingzhi Gong; Peng Ren
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

Review 10.  Molecular Mechanisms That Define Redox Balance Function in Pathogen-Host Interactions-Is There a Role for Dietary Bioactive Polyphenols?

Authors:  Kaiwen Mu; Danni Wang; David D Kitts
Journal:  Int J Mol Sci       Date:  2019-12-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.